Any chance it may put to bed that aspersion towards MSB from a prominent poster from another thread regarding JCR cell QC problems struggling to produce enough cells for 20 agvhd patients in Japan?
Dose not seem to be problem for MSB / Lonza if they are willing to take on another 50 patients on top of the requirements they already have inc possible Sept launch for agvhd?
Cheers BK14
Multisystem Inflammatory Syndrome in Children (MIS-C), page-42
-
- There are more pages in this discussion • 123 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.39 |
Change
-0.005(0.36%) |
Mkt cap ! $1.581B | |||
| Open | High | Low | Value | Volume |
| $1.40 | $1.42 | $1.38 | $4.391M | 3.156M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 48253 | $1.39 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.40 | 32922 | 2 |
View Market Depth
| Last trade - 16.10pm 10/10/2024 (20 minute delay) ? |
| MSB (ASX) Chart |